Chairman’s News | Newsroom | The United States Senate Committee on Finance

May 26,2022

Discussion Draft Release Marks Progress Towards Committee Legislation

Washington, D.C. – Senate Finance Committee Chair Ron Wyden (D-Ore.), Ranking Member Mike Crapo (R-Idaho), Senator Ben Cardin (D-Md.) and Senator John Thune (R-S.D.) today released a discussion draft for telehealth policies as a part of the committee’s ongoing work to improve mental health care across the nation, which has included a public call for comments and three hearings to help develop these initiatives.

“The pandemic made clear that telehealth is a game-changer, particularly so Americans can get mental health care when they need it,” Wyden said. “These policies will

  Read more

Three ways states can reduce health care costs for businesses and consumers

Managing health care costs and enhancing mental health benefits will be top priorities for U.S. employers over the next two years, according to a March 2022 survey of over 600 companies employing 10 million workers. The result isn’t surprising: Health care costs have been a significant expense for employers for many years.

With federal mandates on what health insurance can and cannot look like, there isn’t much that states can do to reverse those trends. But there are policies states can pursue that would save money and increase access to health practitioners without requiring mandates or price caps.

The past

  Read more

Insights on the Liver Health Supplements United States Market to 2027 – Featuring BASF, Bio Botanica and DSM Nutritional Products Among Others

DUBLIN, May 06, 2022–(BUSINESS WIRE)–The “Liver Health Supplements Market Research Report by Product (Herbal Supplements and Vitamins & Minerals), Dosage Form, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The United States Liver Health Supplements Market size was estimated at USD 208.83 million in 2021, USD 223.81 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.15% to reach USD 353.28 million by 2027.

Companies Mentioned

  • AIE Pharmaceuticals, Inc

  • aland Health Holding Ltd

  • Amway India Enterprises Pvt. Ltd.

  • Arizona

  Read more